Mistri, Damiano
Tedone, Nicolò
Biondi, Diana
Vizzino, Carmen
Pagani, Elisabetta
Rocca, Maria A.
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 20 September 2023
Revised: 30 October 2023
Accepted: 5 November 2023
First Online: 26 November 2023
Declarations
:
: DM, DB, NT, CV have no competing interests to declare that are relevant to the content of this article. EP received speakers’ honoraria from Biogen Idec. MF is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, <i>Neurological Sciences,</i> and <i>Radiology</i>; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. MAR received consulting fees from Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche; and speaker honoraria from AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. She receives research support from the MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. She is Associate Editor for <i>Multiple Sclerosis and Related Disorders</i>.
: Approval was obtained from the institutional ethical standards committee on human experimentation of IRCCS Ospedale San Rafaele for any experiments using human subjects (protocol number 2015-33). Written informed consent was obtained from all subjects prior to study participation according to the Declaration of Helsinki.